U.S. markets closed

SPDR S&P Biotech ETF (XBI)

NYSEArca - Nasdaq Real Time Price. Currency in USD
Add to watchlist
133.58-0.80 (-0.60%)
At close: 4:00PM EDT
Sign in to post a message.
  • j
    jim
    $SLS conversation
    Shorts exiting undercover of a Red $xbi probably smart - sls should be $40 or $50 right now - just based on the Phase 3 aml trial nearing FDA approval- 6+ minths from now - should be moving up all the way from here on out.
  • k
    kC
    $SLS conversation
    $XBI Getting Pounded - whole bio sector selling doesn't factor what's about to happen. Smart Money Is Loading on algo discounts.
    Bullish
  • R
    RV
    $BEAM conversation
    BEAM IPO in 2019:
    What was the status of the Beam Therapeutics ( $BEAM ) $100M IPO?

    S-1 came out Sept 2019, near $XBI bottom. Hard to believe JPM/Jefferies/Barclays hasn't launched it given compelling IP + bull market . Not presenting at JPM either
    One theory was:
    -No proof of concept
    -Competition from Prime editing-even from *its own cofounder*.
    -Bad IPO market & won't tolerate these super early-stage cos much longer. Guarantee $BEAM valuation will be reset after IPO
    While others: Others have been "saving dry powder" for $BEAM

    and Verve today:

    At approx $1.3B cap at $30/sh, don’t believe $VERV has much downside
    A unique #CRISPR co is not going to dip below $1B. Even w 50-50 $BEAM rev split
  • k
    kC
    $XBI Is the $SLS Chart Line big funds driving the bus
  • D
    Dude
    $SLS conversation
    Virtually identical chart line as the $XBI --- Will break its grip as the trading day closes- Look at the CALENDAR. There are only 9 Days left in June and two binary billion dollar trial results are IMMINENT.
    Bullish
  • k
    kC
    Rode the $XBI CHART LINE ALL DAY - Virtually Identical Red line
  • D
    Dude
    Two Trial RESULTS IMMINENT $SlS bucking the downward $XBI trend
    Phase 2 Ovarian cancer readout in combination with Keytruda/ Mesothelioma combination trial with Opdivo.
    Each trial in end stage patients who have no further treatment options.
    Bullish
  • j
    james
    I have been able to complete my position here with the last two days of Bios selling off . Congrats to everyone else who has discovered this gem. Please see my posts for all the Diligence done and you'll understand. I also agree with Mike below. Dr Weber, NCI 10 years, laughs at a $250 target.
  • v
    vic
    $NVAX conversation
    $XBI being a leading indicator of NVAX today thus far. its trading about 10 seconds behind the XBI, tick by tick...XBI goes up....10 seconds later NVAX follows.
  • E
    Ez$
    $SLS conversation
    $sls is on the $xbi chart trending down now
    does that mean the big funds are already in control? it would not surprise me one bit to see the next round of 13fs show funds triple in here AGAIN this quarter
  • F
    Faust
    It’s Biotech month!
  • D
    Dude
    $SLS conversation
    Charting on the same Pattern as the $XBI - Bio ETFS and Institutional funds must have been buying a full S Ton this quarter too - control the price now. We will see the 13F's show lots more funds loaded into positions.
  • D
    Dude
    $SLS conversation
    $XBI Is the $SLS Chart Line
  • E
    Ez$
    $SLS conversation
    $12.50 will be $125 in 6-9 months time $xbi Algo's offering up the last best discounts right now IMO
  • D
    Dude
    $SlS surging with a diving $XBI
    6/3 Binary News buy the rumour sell the news pump n dump or real and true value creation? Phase 2 Ovarian cancer readout in combination with Keytruda/ Mesothelioma combination trial with Opdivo.
    Bullish
  • G
    G$
    $SLS conversation
    Eod Bio sector $XBI tankage but not SLS - $SLS Stood Strong very good news for longs.
  • F
    FIXER
    $vxrt #1 holding $xbi biotech etf
  • A
    AlrightAlright_Alright
    $HGEN conversation
    $HGEN is now the number one holding in Biotech ETF $XBI. It was also added to the following new ETF's.

    - iShares Core S&P Total U.S. Stock Market ETF, $ITOT
    - MSCI Global Small Cap

    Institutional Holding are now up to 39.69%

    Things are getting serious.
    Bullish
  • F
    Faust
    Biotech season just about to begin, buy-O- tech
    Bullish
  • D
    Dude
    Again $sls uptick towards the close while the $xbi takes one in the groin. 6/3 news building the pressure.